SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 140 filers reported holding SERES THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $8 | -89.0% | 10,376 | -80.1% | 0.00% | -100.0% |
| Q4 2023 | $73 | -70.6% | 52,080 | +19.2% | 0.00% | -66.7% |
| Q1 2023 | $248 | +210.0% | 43,684 | +206.6% | 0.00% | +200.0% |
| Q4 2022 | $80 | -99.9% | 14,247 | -10.5% | 0.00% | 0.0% |
| Q3 2022 | $102,000 | +2.0% | 15,916 | +32.4% | 0.00% | 0.0% |
| Q4 2021 | $100,000 | -97.3% | 12,018 | -97.7% | 0.00% | -94.1% |
| Q3 2021 | $3,688,000 | +913.2% | 529,935 | +3372.7% | 0.02% | +750.0% |
| Q2 2021 | $364,000 | +4.9% | 15,260 | -9.5% | 0.00% | 0.0% |
| Q1 2021 | $347,000 | -25.1% | 16,859 | -10.7% | 0.00% | 0.0% |
| Q4 2020 | $463,000 | +245.5% | 18,885 | -33.0% | 0.00% | +100.0% |
| Q2 2020 | $134,000 | +294.1% | 28,188 | +167.9% | 0.00% | – |
| Q2 2019 | $34,000 | – | 10,523 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $131,073,645 | 5.09% |
| Lion Point Capital, LP | 596,803 | $3,383,873 | 1.39% |
| Eversept Partners, LP | 2,536,665 | $14,382,891 | 1.00% |
| Knott David M Jr | 315,000 | $1,786 | 0.70% |
| Kynam Capital Management, LP | 768,913 | $4,359,737 | 0.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,525 | $1,318,417 | 0.54% |
| Simplify Asset Management Inc. | 550,626 | $3,122,049 | 0.45% |
| Atom Investors LP | 90,388 | $512,500 | 0.28% |
| FEDERATED HERMES, INC. | 15,277,356 | $86,622,609 | 0.22% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 47,796 | $271,003 | 0.17% |